Glutathione: How Diet, Precursors, and Supplements Protect Against Aging

Glutathione (GSH) is the body's most abundant intracellular antioxidant, yet its levels decline predictably with age, leaving cells increasingly vulnerable to oxidative stress, inflammation, and toxic burden. This 2026 narrative review, drawing on 109 peer-reviewed sources identified from PubMed and Google Scholar (2015–2026), systematically evaluates what GSH does in the body and how best to maintain it through diet, precursors, or supplementation.

GSH is a tripeptide (γ-Glu-Cys-Gly) whose cysteine thiol group provides its core reducing power. It is synthesized in two ATP-dependent cytosolic steps: glutamate-cysteine ligase (the rate-limiting enzyme) first forms γ-glutamylcysteine, then glutathione synthetase adds glycine. Cysteine availability is typically the bottleneck for synthesis, making cysteine-supplying foods and supplements particularly valuable.

The review organizes GSH's physiological roles into five domains. As an antioxidant, GSH neutralizes reactive oxygen and nitrogen species, prevents lipid peroxidation, and works synergistically with glutathione peroxidase and glutathione S-transferase. In detoxification, it conjugates xenobiotics—drugs, carcinogens, heavy metals, mycotoxins, and polycyclic aromatic hydrocarbons—enabling their excretion. For immune regulation, GSH maintains regulatory T-cell function, modulates inflammasome activation, supports trained immunity, and helps control fever responses. Mitochondrially, adequate GSH improves membrane potential, reduces ROS production, supports iron–sulfur cluster biosynthesis, and prevents apoptotic pore opening. In chronic disease, low GSH correlates with cardiovascular disease, neurodegeneration, insulin resistance, and cancer susceptibility—while paradoxically, elevated GSH in established tumors can drive drug resistance.

On the critical question of how to raise GSH levels, the review finds that orally ingested GSH from food is largely hydrolyzed in the gut before reaching systemic circulation, limiting its direct utility. Precursor strategies—particularly glycine and γ-glutamylcysteine supplementation, along with Nrf2-activating phytochemicals such as sulforaphane—show the strongest and most consistent increases in human tissue GSH. A protein-rich diet supplying all three constituent amino acids, combined with sulfur-rich vegetables (cruciferous, allium) and targeted precursor supplements, is identified as the most evidence-supported approach.

For aging populations and those with oxidative stress-related diseases, the authors conclude that precursor-based supplementation combined with a phytochemical-dense diet offers the most robust strategy for sustained GSH elevation, superior to direct oral GSH alone. Caveats include reliance on heterogeneous study designs and limited long-term human RCT data.